{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Incomplete understanding of infectiousness changes over time\",\"Impact\":\"Inaccurate assessment of transmission dynamics and ineffective disease control measures\",\"Mitigation\":\"Regularly update and validate the mathematical model with real-world data on infectiousness changes\",\"Technologies\":\"Mathematical modeling, real-time data analytics\",\"People\":\"Public health officials, epidemiologists\",\"Owner\":\"Government health agencies, research institutions\"},{\"Description\":\"Inadequate sensitivity and specificity of biosensors for COVID-19 detection\",\"Impact\":\"False-negative or false-positive results, leading to ineffective disease management and resource wastage\",\"Mitigation\":\"Rigorous testing and validation of biosensor performance, optimization of probe specificity and sensitivity\",\"Technologies\":\"Biorecognition elements, sensor surface chemistry\",\"People\":\"Biomedical engineers, researchers, healthcare professionals\",\"Owner\":\"Biotechnology companies, healthcare institutions\"},{\"Description\":\"Lack of rapid and multiplexity in diagnostic tools for COVID-19\",\"Impact\":\"Delayed detection of multiple biomarkers, hindering early diagnosis and treatment\",\"Mitigation\":\"Development of rapid multiplex diagnostic platforms with high accuracy\",\"Technologies\":\"Multiplex diagnostic platforms, rapid testing technologies\",\"People\":\"Clinical diagnosticians, healthcare professionals\",\"Owner\":\"Medical device manufacturers, research and development teams\"}]}"}}